
|Videos|June 12, 2015
Immediate Impacts of Health-System Pharmacists as Providers
Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.
Advertisement
Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.
This video was recorded at ASHP's Summer Meeting and Exposition in June 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
5












































































































































































































